NCT01711528 2018-05-11Dinaciclib, Bortezomib, and Dexamethasone in Treating Patients With Relapsed Multiple MyelomaNational Cancer Institute (NCI)Phase 1 Completed41 enrolled
NCT01096342 2014-06-18Dinaciclib in Treating Patients With Relapsed or Refractory Multiple MyelomaNational Cancer Institute (NCI)Phase 2 Completed16 enrolled 6 charts